MDB.WAR Medicofarma Biotech S.A.
- Market cap
- PLN 22.8M
- P/E
- -
- P/B
- 5.55x
- ROE
- -52.1%
- Dividend yield
- -
- Fundamental score
- 0.4/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is MDB.WAR undervalued?
Graham numberThe Graham number of Medicofarma Biotech S.A. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Medicofarma Biotech S.A. fundamental analysis
2 of 21 checks passedROE 0/2
Low return on equity (-52.1%), below 10%.
ROA 1/1
Return on assets (-17.5%) is above the industry median (-18.6%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (3.0%) is above the industry median (2.6%).
Revenue Growth 0/2
Revenue shrank 69.6% a year over the past 3 years.
Short-term Liquidity 0/1
Current assets do not cover short-term liabilities.
Long-term Liabilities 0/1
Current assets do not cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 0/2
Cash runway cannot be calculated.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book (5.1x) is above the industry median (3.6x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Medicofarma Biotech S.A. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Medicofarma Biotech S.A.
Medicofarma Biotech SA engages in the research and development of medicines, medicinal products, and biotechnology products in Poland. The company offers staff support and equipment during the early stages of development of generic pharmaceutical products and cosmetics, as well as analytical examinations. It also provides MediPAN COVID SARS-CoV-2 test, a screening test for detecting the SARS-CoV-2 virus; and real-time PCR genetic tests. The company was formerly known as Inbo…
Full company profileMedicofarma Biotech S.A. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Medicofarma Biotech S.A. annual financial statements (PLN; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 4.25M | 751K | 1.22M | 120K | 140K |
| Gross Profit | 1.06M | 491K | 1.05M | -73.6K | -43.5K |
| Operating Income | -1.58M | -2.54M | -2.07M | -1.61M | -2.44M |
| EBITDA | 165K | -1.49M | -532K | -215K | -801K |
| Net Income | -1.59M | -3.44M | -2.30M | -2.23M | -2.35M |
| EPS | -0.02 | -0.05 | -0.03 | -0.03 | -0.03 |
| Balance Sheet | |||||
| Total Assets | 16.4M | 15.0M | 14.7M | 14.2M | 13.5M |
| Total Liabilities | 3.76M | 5.80M | 7.84M | 8.52M | 8.96M |
| Shareholders' Equity | 12.6M | 9.18M | 6.87M | 5.68M | 4.51M |
| Cash & Short-term Investments | 508K | 5.23K | 6.24K | 1.74K | - |
| Cash Flow | |||||
| Operating Cash Flow | 960K | 7.26K | -1.02M | -984K | -702K |
| Capital Expenditure | 1.21M | 1.11M | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -248K | -1.10M | -1.02M | -984K | -702K |
| Ratios | |||||
| ROE | -12.6% | -37.5% | -33.5% | -39.2% | -52.1% |
| ROA | -9.7% | -23.0% | -15.6% | -15.7% | -17.5% |
| Net Profit Margin | -37.4% | -458.1% | -187.8% | -1,860.3% | -1,678.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Medicofarma Biotech S.A. dividends
Medicofarma Biotech S.A. has not paid dividends in the last 4 fiscal years.
Last stock split: 1:10 on Nov 8, 2011.
Who owns Medicofarma Biotech S.A.
- Insiders 79.66%
- Institutions 0.00%
- Public & others 20.34%
- Shares outstanding 68.0M
- Free float 12.9M
Medicofarma Biotech S.A. company profile
- Company name
- Medicofarma Biotech S.A.
- Ticker
- MDB.WAR
- ISIN
- PLINBOK00010
- Exchange
- Warsaw Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 7
- Fiscal year end
- December
- Address
- Sokolowska 9/lok.U19, Warsaw, Poland, 01-142
- Phone
- 48 32 268 6405
- Website
- medicofarmabiotech.pl
About Medicofarma Biotech S.A.
Medicofarma Biotech SA engages in the research and development of medicines, medicinal products, and biotechnology products in Poland. The company offers staff support and equipment during the early stages of development of generic pharmaceutical products and cosmetics, as well as analytical examinations. It also provides MediPAN COVID SARS-CoV-2 test, a screening test for detecting the SARS-CoV-2 virus; and real-time PCR genetic tests. The company was formerly known as Inbook Spólka Akcyjna and changed its name to Medicofarma Biotech SA in February 2021. Medicofarma Biotech SA was founded in 2001 and is headquartered in Warsaw, Poland. Medicofarma Biotech SA operates as a subsidiary of Vitama Spolka Akcyjna.
Medicofarma Biotech S.A. management
2- Mr. Cezary KilczewskiChairman of the Management Board
- Ms. Dorota Saczynska-WlodarczykChief Accountant